...
首页> 外文期刊>RSC Advances >Binding mechanism of nine N-phenylpiperazine derivatives and alpha(1A)-adrenoceptor using site-directed molecular docking and high performance affinity chromatography
【24h】

Binding mechanism of nine N-phenylpiperazine derivatives and alpha(1A)-adrenoceptor using site-directed molecular docking and high performance affinity chromatography

机译:使用位点定向分子对接和高性能亲和色谱法,九苯基哌嗪衍生物和α(1A) - α(1A) - 高效亲和色谱法的结合机理

获取原文
获取原文并翻译 | 示例
           

摘要

N-Phenylpiperazine derivatives are widely used as clinical drugs for fighting diseases related to the cardiovascular system by mediating the signal pathway of alpha(1)-adrenoceptor. The binding mechanism of nine N-phenylpiperazine derivatives to alpha(1A)-adrenoceptor was explored using molecular docking and high performance affinity chromatography. The methodology involved homology modelling of the three dimensional structure of alpha(1A)-adrenoceptor, predication of the binding behaviors using LIBDOCK and investigation of the thermodynamic behaviors of the binding by frontal analysis. Molecular docking results showed that Asp(106), Gln(177), Ser(188), Ser(192) and Phe(193) of the receptor were the main binding sites for the nine N-phenylpiperazine derivatives binding to alpha(1A)-adrenoceptor. The binding was driven by formation of hydrogen bonds and electrostatic forces. The affinity of these derivatives for the receptor depended on the functional groups of an ionizable piperazine, hydrogen bond acceptor and hydrophobic moiety in the ligand structures. Frontal analysis indicated that the association constants of these compounds for the receptor were determined by their structural deviations in the above-mentioned functional groups. Thermodynamic studies presented negative enthalpy and Gibbs free energy changes with a positive entropy change, providing proof that the binding of the derivatives to alpha(1A)-adrenoceptor was mainly driven by electrostatic forces. This result was in line with the binding mechanism predicted by molecular docking. It is possible to explore the binding mechanism of drug candidates specifically binding to alpha(1A)-adrenoceptor using receptor chromatography.
机译:N-苯基哌嗪衍生物被广泛用作通过介导α(1)-Adrenceptor的信号途径来对抗心血管系统相关的疾病的临床药物。利用分子对接和高性能亲和层析探索九苯基哌嗪衍生物与α(1A)的结合机制衍生物。该方法涉及α(1A) - 肾上腺素受体的三维结构的同源性建模,利用腹下使用腹层分析对结合的热力学行为的预测行为的预测。分子对接结果表明,受体的ASP(106),GLN(177),SER(188),SER(192)和PHE(193)是九个N-苯基哌嗪衍生物与α(1A)结合的主要结合位点-Adrenoceptor。通过形成氢键和静电力来驱动结合。这些衍生物对受体的亲和力依赖于配体结构中可电离哌嗪,氢粘合受体和疏水部分的官能团。正面分析表明,这些化合物的关联常数通过其上述官能团中的结构偏差确定。热力学研究呈现阴性焓和吉布斯自由能量随着阳性熵变化而变化,提供了衍生物与α(1A) - 肾上腺素受体的结合主要由静电力驱动。该结果与分子对接预测的结合机制一致。可以使用受体色谱法探讨药物候选物特异性结合α(1A)-Drenceptor的药物候选物的结合机制。

著录项

  • 来源
    《RSC Advances》 |2015年第70期|共8页
  • 作者单位

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

    Peking Univ Inst Vasc Med Hosp &

    Key Lab Mol Cardiovasc Sci 3 Minist Educ Beijing 100083 Peoples R China;

    Peking Univ Inst Vasc Med Hosp &

    Key Lab Mol Cardiovasc Sci 3 Minist Educ Beijing 100083 Peoples R China;

    NW Univ Xian Coll Life Sci Key Lab Resource Biol &

    Biotechnol Western China Minist Educ Xian 710069 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号